proteomic changes upon treatment with semaglutide in individuals with obesity Change body weight 2.4 mg: STEP trials [95–98] Semaglutide impacts skeletal muscle to

The injectable form delivers a higher, more consistent dose of semaglutide, which has been shown in studies to result in greater reductions in body weight compared to the oral version

Age-related patterns Age influences GLP-1 transformation in several ways

By increasing insulin secretion, semaglutide helps lower blood sugar levels after meals

The body becomes stuck in a chronic state of immune system overload, adrenal insufficiency, gut dysbiosis, impaired digestion, inflammation, and thyroid hormone release abnormalities

Because of this difference, GLP-1 agonists are often preferred when weight loss is a primary goal in diabetes management